Literature DB >> 36063180

Lactobacillus casei displaying Clostridium perfringens NetB antigen protects chickens against necrotic enteritis.

Mohammad Ali Shamshirgaran1, Mehdi Golchin2, Elham Mohammadi1.   

Abstract

Necrotic enteritis is a serious economical disease of poultry caused by Clostridium perfringens. NetB toxin of Clostridium perfringens is considered the causative agent of necrotic enteritis. Following the withdrawal of in-feed antibiotic growth promoters, there has been an urgent need to develop alternative approaches such as vaccination. Currently, there are no commercially available vaccines to control necrotic enteritis especially in broiler chickens as the target population. In the present study, we constructed a recombinant Lactobacillus casei strain expressing NetB protein of C. perfringens on the cell surface and used this probiotic-based vaccine strain to immunize broiler chickens orally against experimental induction of necrotic enteritis. The birds immunized with the oral vaccine strain were significantly protected against necrotic enteritis challenge and developed strong serum anti-NetB antibody responses to NetB protein. Furthermore, the immunized birds showed higher body weight gains during the challenge experiment compared with control birds. This study showed, for the first time, that a probiotic-based vector vaccine could be a promising vaccine candidate to provide protection against necrotic enteritis in broiler chickens. KEYPOINTS: • The probiotic L. casei carrying pT1NX-netB plasmid displayed NetB antigen on the cell surface. • The LC-NetB vaccine strain induced high anti-toxin antibody response in broiler chickens. • The LC-NetB vector vaccine provided significant protection against experimental NE challenge.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Clostridium perfringens; Lactobacillus casei; Necrotic enteritis; NetB toxin; Probiotic; Vector vaccine

Mesh:

Substances:

Year:  2022        PMID: 36063180     DOI: 10.1007/s00253-022-12155-y

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   5.560


  33 in total

1.  A Recombinant Probiotic, Lactobacillus casei, Expressing the Clostridium perfringens α-toxoid, as an Orally Vaccine Candidate Against Gas Gangrene and Necrotic Enteritis.

Authors:  Mojtaba Alimolaei; Mehdi Golchin; Jalil Abshenas; Majid Ezatkhah; Mehrdad Shamsaddini Bafti
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

2.  Oral immunization of mice against Clostridium perfringens epsilon toxin with a Lactobacillus casei vector vaccine expressing epsilon toxoid.

Authors:  Mojtaba Alimolaei; Mehdi Golchin; Hamid Daneshvar
Journal:  Infect Genet Evol       Date:  2016-03-21       Impact factor: 3.342

Review 3.  Clostridium perfringens in poultry: an emerging threat for animal and public health.

Authors:  Filip Van Immerseel; Jeroen De Buck; Frank Pasmans; Gerard Huyghebaert; Freddy Haesebrouck; Richard Ducatelle
Journal:  Avian Pathol       Date:  2004-12       Impact factor: 3.378

4.  Vaccination with Clostridium perfringens recombinant proteins in combination with Montanide™ ISA 71 VG adjuvant increases protection against experimental necrotic enteritis in commercial broiler chickens.

Authors:  Seung I Jang; Hyun S Lillehoj; Sung-Hyen Lee; Kyung Woo Lee; Erik P Lillehoj; Yeong Ho Hong; Dong-Jun An; Wooseog Jeong; Ji-Eun Chun; François Bertrand; Laurent Dupuis; Sébastien Deville; Juliette Ben Arous
Journal:  Vaccine       Date:  2012-06-17       Impact factor: 3.641

Review 5.  The European ban on growth-promoting antibiotics and emerging consequences for human and animal health.

Authors:  Mark Casewell; Christian Friis; Enric Marco; Paul McMullin; Ian Phillips
Journal:  J Antimicrob Chemother       Date:  2003-07-01       Impact factor: 5.790

6.  Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines.

Authors:  Yakhya Dieye; Arjan J W Hoekman; Florence Clier; Vincent Juillard; Hein J Boot; Jean-Christophe Piard
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

7.  Reduced lesions in chickens with Clostridium perfringens-induced necrotic enteritis by Lactobacillus fermentum 1.20291.

Authors:  Li Cao; Cao Li; X J Yang; Z J Li; F F Sun; X H Wu; J H Yao
Journal:  Poult Sci       Date:  2012-12       Impact factor: 3.352

8.  Quantification of gut lesions in a subclinical necrotic enteritis model.

Authors:  Ahmad R Gholamiandehkordi; Leen Timbermont; Anouk Lanckriet; Wim Van Den Broeck; Karl Pedersen; Jeroen Dewulf; Frank Pasmans; Freddy Haesebrouck; Richard Ducatelle; Filip Van Immerseel
Journal:  Avian Pathol       Date:  2007-10       Impact factor: 3.378

9.  Recombinant Bacillus subtilis expressing the Clostridium perfringens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis.

Authors:  Tran H Hoang; Huynh A Hong; Graeme C Clark; Richard W Titball; Simon M Cutting
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441

10.  Surface-displayed porcine epidemic diarrhea viral (PEDV) antigens on lactic acid bacteria.

Authors:  Xi-Lin Hou; Li-Yun Yu; Jianzhu Liu; Gui-Hua Wang
Journal:  Vaccine       Date:  2007-11-20       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.